Physician profile
David J Smith
NPI 1811930357
$6,640.78
in general payments reported to CMS, 2019-2025
31 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,726 · 2020: $850 · 2021: $2,685 · 2022: $344 · 2023: $554 · 2024: $320 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Spine, LLC | $2,200.00 | 2021 | |
| Nevro Corp. | $685.77 | 2019-2022 | |
| Medtronic USA, INC. | $665.49 | 2019-2020 | |
| Biotronik Nro, INC. | $591.94 | 2023-2024 | Biotronik, Prospera |
| Vertiflex, INC. | $589.85 | 2019 | |
| Saol Therapeutics INC. | $568.33 | 2019 | |
| Medtronic, INC. | $239.18 | 2021-2025 | Inceptiv |
| Spr Therapeutics, INC | $202.09 | 2022-2023 | Sprint Pns System |
| Forte Bio-Pharma LLC | $164.87 | 2020-2021 | |
| Grt US Holding, INC. | $85.46 | 2022 | |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Boston Scientific Corporation | $61.84 | 2021-2023 | Wolverine Coronary Cutting Balloon |
| Stryker Corporation | $40.70 | 2021 | |
| Impactortho, INC. | $40.67 | 2021 | |
| Nalu Medical, INC. | $39.84 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $37.14 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $33.67 | 2022 | |
| Bard Peripheral Vascular, INC. | $33.67 | 2020 | |
| Zimvie INC. | $33.67 | 2022 | |
| Tersera Therapeutics LLC | $28.68 | 2022 | |
| Spinal Simplicity, LLC | $23.97 | 2022 | |
| Globus Medical, INC. | $23.58 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $23.14 | 2022 | |
| Janssen Biotech, INC. | $22.96 | 2021 | |
| Vertos Medical, INC. | $22.74 | 2024 | Mild Device Kit |
| Daiichi Sankyo INC. | $22.06 | 2024 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $21.98 | 2019 | |
| Pfizer INC. | $17.16 | 2019 | |
| Lilly USA, LLC | $14.74 | 2022 | |
| Allergan, INC. | $11.58 | 2019 | |
| Veran Medical Technologies, INC. | $10.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.